Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain

Journal of Clinical Virology

Volumn 51, Issue 3, 2011, Pages 205-208

  Ledesma, Juan ^a   Vicente, Diego ^b   Pozo, Francisco ^a   Cilla, Gustavo ^b   Castro, Sonia Pérez ^c   Fernández, Jonathan Suárez ^c   Ruiz, Mercedes Pérez ^d   Navarro, José María ^d   Galán, Juan Carlos ^e   Fernández, Mirian ^f   Reina, Jordi ^g   Larrauri, Amparo ^h   Cuevas, María Teresa ^a   Casas, Inmaculada ^a   Breña, Pilar Pérez ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c Servicio de Microbiología del Complejo Hospitalario Universitario ^*  (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f UNIVERSITY CLINIC OF NAVARRA   (Spain)

^g HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^h CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

H275Y mutation; Influenza; Neuraminidase; Oseltamivir resistance

Indexed keywords

OSELTAMIVIR; SIALIDASE;

2009 H1N1 INFLUENZA; ANTIVIRAL RESISTANCE; ARTICLE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; PANDEMIC; PRIORITY JOURNAL; SPAIN; VIRUS DETECTION;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MUTATION, MISSENSE; NEURAMINIDASE; NUCLEIC ACID HYBRIDIZATION; OSELTAMIVIR; PANDEMICS; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SPAIN; VIRAL PROTEINS;

EID: 79959195235     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.04.008     Document Type: Article

References (21)

1. Center for Disease Control and Prevention (CDC) Update: swine influenza A (H1N1) infections-California and Texas, April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:435-437.
2. Center for Disease Control and Prevention (CDC) Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:467-470.
3. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2606-2615.
4. Deyde V.M., Xu X., Bright R.A., Shaw M., Smith C.B., Zhang Y., et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007, 196:249-257.
5. Ferraris O., Lina B. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol 2008, 41:13-19.
6. Abed Y., Baz M., Boivin G. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus. J Infect Dis 2009, 199:180-183.
7. Wang M.Z., Tai C.Y., Mendel D.B. Mechanism by which mutations at His274 alter sensitivity of influenza A virus N1 neuraminidase to oseltamivir carboxylate and zanamivir. Antimicrob Agents Chemother 2002, 46:3809-3816.
8. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
9. Gubareva L.V., Trujillo A.A., Okomo-Adhiambo M., Mishin V.P., Varough M.D., Sleeman K., et al. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus turing susceptibility in vitro. Antivir Ther 2010, 15:1151-1159.
10. Center for Disease Control and Prevention (CDC) Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients-Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:893-896.
11. World Health Organization. Weekly update on oseltamivir resistance to influenza H1N1 (2009) viruses. http://www.who.int/csr/disease/influenza/2010_11_08_GIP_surveillance/en/index.html.
12. World Health Organization. Clinical management of human infection with pandemic (H1H1) 2009: revised guidance. http://www.who.int/csr/resources/publications/swineflu/clinical_management/en/index.html.
13. Ministerio de Sanidad, Política Social e Igualdad, Subcomité de Vigilancia. Plan Nacional de Preparación y Respuesta ante una pandemía de gripe. Actuaciones ante la detección de casos de infección por nuevo virus de la gripe A (H1N1). http://www.mspsi.es/profesionales/saludPublica/gripeA/docs/ActuacionesVirusPandemico2009.pdf.
14. Ruiz-Carrascoso G., Casas I., Pozo F., Perez-Gonzalez C., Reina J., Perez-Brena P. Development and implementation of influenza a virus subtyping and detection of genotypic resistance to neuraminidase inhibitors. J Med Virol 2010, 82:843-853.
15. Wang B., Dwyer D.E., Blyth C.C., Soedjono M., Shi H., Kesson A., et al. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antivir Res 2010, 87:16-21.
16. Tramontana A.R., George B., Hurt A.C., Doyle J.S., Langan K., Reid A.B., et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 2010, 16:1068-1075.
17. Chidlow G.R., Harnett G.B., Williams S.H., Tempone S.S., Speers D.J., Hurt A.C., et al. The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay. J Virol Methods 2010, 169(1):47-51.
18. Harvala H., Gunson R., Simmonds P., Hardie A., Bennett S., Scott F., et al. The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill 2010, 15.
19. Hauge S.H., Dudman S., Borgen K., Lackenby A., Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1) Norway, 2007-08. Emerg Infect Dis 2009, 15:155-162.
20. Zonis Z., Engelhard D., Hindiyeh M., Ram D., Mandelboim M., Mendelson E., et al. Community-acquired oseltamivir-resistant pandemic (H1N1) 2009 in Child Israel. Emerg Infect Dis 2010, 16:1045-1046.
21. Chen H., Cheung C.L., Tai H., Zhao P., Chan J.F., Cheng V.C., et al. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong China. Emerg Infect Dis 2009, 15:1970-1972.